Lapatinib Tablet is anti-cancer medicine which is also suitable to be used for the treatment of solid tumors. Considered as a dual tyrosine kinase inhibitor, it is indicated for breast cancer in combination with therapy for HER2/neu. This tablet is known to work by interrupting the epidermal growth factor receptor and HER2/neu. It gets metabolized in the liver by CYP3A4 with protein binding ability of more than 99%. Lapatinib has molecular formula C29H26ClFN4O4S with a molar mass of 581.058 g/mol. Lapatinib Tablet has elimination half-life of about 24 hours with multiple doses with excretion mainly in feces.Lapatinib TabletProduct Details:
- Minimum Order Quantity: 50 Box
- Dose: 250 mg
- Packaging Size: 42 Tablets
- Packaging Type: Box
- Usage: Commercial, Clinical, Hospital, Personal
We are leading Exporter and Manufacturer of Lapatinib Tablet.
Uses: Lapatinib is used in the treatment of breast cancer
How it works: Lapatinib In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Lapatinib blocks this signal, and thus stops the production of these cancer cells.
Common side effects: Nausea, Headache, Back pain, Breathing difficulty, Rash, Joint pain, Pain in extremity, Insomnia, Vomiting, Abdominal pain, Loss of appetite, Dyspepsia, Hot flushes, Diarrhoea, Cough, Nose bleed, Constipation, Stomatitis
Tag: Lapatinib Tablets exporter, Lapatinib Tablets manufacturer